In addition, natural compounds such as acacetin inhibit NLRP3 inflammasome activation by decreasing ROS production and inhibiting ASC aggregation, showing potential as therapeutic candidates for AD (116). The gene discussed is NLRP3; the disease is Alzheimer disease.